Allergy Diagnostics And Therapeutics Market Analysis By Product (Instruments, Consumables, Services), By Allergen Type (Food, Inhaled, Drug), By End-use (Academic Research Institutes, Hospitals, Diagnostic Laboratories), By Test (In Vivo, In Vitro), By Drug Class (Antihistamines, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Decongestants, Immunomodulators, Autoinjectable Epinephrine, Immunotherapy) And Segment Forecasts To 2022

Published: Jan, 2016 | Pages: 92 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

Global allergy diagnostics and therapeutics market is expected to reach USD 40.8 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of allergic conditions and adoption of immunoassay as a viable diagnostic test is expected to serve this market with lucrative future growth opportunities.

The prevalence of target diseases such as asthma and food allergies are expected to grow over the next seven years, supported by sedentary and dietary lifestyle habits. In addition, rising indoor, industrial pollution, rapid urbanization in developing countries and increasing greenhouse gas concentrations are expected to increase the prevalence of pollen induced respiratory disorder, thereby boosting the overall market growth over the forecast period.

Increasing incidences of allergies has triggered the demand for sensitive, cost effective and accurate diagnostics tools. Manufacturers in congruence with the changing customer preferences are now engaged in constant product development. For instance, the MeDALL allergen-chip for allergy determination is further expected to propel market growth during the next seven years.

Further key findings from the study suggest:

Consumables being an indispensable diagnostic product segment sell in large volumes and therefore, dominated the market in 2014 with revenue share of over 55.0%. In addition, expensive nature of reagents and their frequent application in diagnostic assay also supports the aforementioned fact.

Increasing demand for analyzers and laminators for allergy diagnostics is expected to help this segment grow at a lucrative CAGR of above 12.0% over the forecast period. Increasing awareness pertaining to outsourcing of allergy testing services is anticipated to show upward shift in coming years.

Increasing demand for minimally invasive and allergen specific tests is anticipated to serve in vitro allergy diagnostics market with future growth opportunities. The market is expected to grow with CAGR of above 12.0% over the forecast period.

Inhaled allergens accounted for the largest share of revenue in 2014 owing to, the growing incidences of respiratory allergies. According to statistics published in 2012 by American Academy of Allergy Asthma and Immunology (AAAAI), around 7.8 million children suffered from respiratory allergies worldwide and the number is expected to increase over the forecast period.

Hospitals are the largest consumer of allergy diagnostic products. The segment is anticipated to grow with CAGR of over 11.0% in coming years.
Antihistamines were the largest allergy therapeutic segment as of 2014 with share valued at over 17.0% due to associated advantages such as non sedating nature of drugs and minimum side effects with use of second generation antihistamines in allergy treatment.

Immunotherapy vaccines are expected to witness lucrative growth owing to extensive R&D coupled with the introduction of sublingual immunotherapy tablets in the treatment of allergic rhinitis. For instance, In April 2014, the U.S. FDA announced the approval of a five-grass pollen sublingual tablet (Ex-Oralair) produced by Stallergenes which are used in the treatment of pollen allergy.

Some key players of this market include Thermo Fisher Scientific, Omega Diagnostics, Siemens Healthcare, Stallergenes Greer, Lincoln Diagnostics, bioMerieux, HOB Biotech Group, Alcon Laboratories, Hycor Biomedical and Hitachi Chemical Diagnostics.

Industry players are focusing on introducing technologically advanced and innovative products to gain competitive advantage. For instance, in March 2015, Stallergenes received approval for STG 320 in Japan, which is the first sublingual immunotherapy tablet used in the treatment of house dust mite allergy.

 Table of Content

Chapter 1 Methodology and Scope
                   1.1 Country wise market calculation
                   1.2 Region based segment share calculation
                   1.3 Primary Sources
                   1.4 List of secondary sources
Chapter 2 Executive Summary
Chapter 3 Allergy Diagnostics Industry Outlook
                   3.1 Market segmentation
                   3.2 Market size and growth prospects
                   3.3 Allergy Diagnostics: Market dynamics
                      3.3.1 Market driver analysis
                           3.3.1.1 Increasing incidences of allergy diseases
                           3.3.1.2 Increasing demand for IVD tests for allergy diagnosis
                           3.3.1.3 Introduction of technologically advance allergy diagnostics products
                           3.3.1.4 Growing healthcare expenditure triggering development of effective allergy diagnostic & therapeutic products
                      3.3.2 Market restraint analysis
                           3.3.2.1 Low adoption and penetration in developing countries due to high cost of technology
                           3.3.2.2 Presence of ambiguous regulatory framework
                   3.4 Industry analysis - Porter's
                   3.5 Key Opportunities Prioritized & Platform Positioning
                      3.5.1 Key Opportunities Prioritized
                   3.6 Allergy Diagnostics Competitive Landscape, 2014
                      3.6.1 Company Market Share Analysis, 2014
                      3.6.2 Competitive Landscape: Market Position Analysis
                   3.7 Pipleline Aanlysis: Allergy Therapeutics
                   3.8 Allergy Diagnostics- PESTEL analysis
Chapter 4 Allergy Diagnostics Product Outlook
                   4.1 Allergy diagnostics market share, by product, 2014 & 2022
                   4.2 Instruments
                      4.2.1 Instruments market, 2012 - 2022 (USD Million)
                   4.3 Consumables
                      4.3.1 Consumables market, 2012 - 2022 (USD Million)
                   4.4 Services
                      4.4.1 Services market, 2012 - 2022 (USD Million)
Chapter 5 Allergy Diagnostics Allergen Type Outlook
                   5.1 Allergy diagnostics market share, by allergen type, 2014 & 2022
                   5.2 Food Allergen
                      5.2.1 Food Allergen market, 2012 - 2022 (USD Million)
                   5.3 Inhaled Allergen
                      5.3.1 Inhaled allergen market, 2012 - 2022 (USD Million)
                   5.4 Drug Allergen
                      5.4.1 Drug allergen market, 2012 - 2022 (USD Million)
                   5.5 Other
                      5.5.1 Other market, 2012 - 2022 (USD Million)
Chapter 6 Allergy Diagnostics End-use Outlook
                   6.1 Global allergy diagnostics market share, by end-use, 2014 & 2022
                   6.2 Academic Research Institutes
                      6.2.1 Academic research institutes market, 2012 - 2022 (USD Million)
                   6.3 Hospitals
                      6.3.1 Hospitals market, 2012 - 2022 (USD Million)
                   6.4 Diagnostic Laboratories
                      6.4.1 Diagnostic laboratories market, 2012 - 2022 (USD Million)
Chapter 7 Allergy Diagnostics Test Outlook
                   7.1 Global allergy diagnostics market share, by test, 2014 & 2022
                   7.2 In vivo test
                      7.2.1 In vivo test market, 2012 - 2022 (USD Million)
                      7.2.2 Skin prick test
                           7.2.2.1 Skin prick test market, 2012 - 2022 (USD Million)
                      7.2.3 Intradermal test
                           7.2.3.1 Intradermal test market, 2012 - 2022 (USD Million)
                      7.2.4 Patch test
                           7.2.4.1 Patch test market, 2012 - 2022 (USD Million)
                   7.3 In vitro test
                      7.3.1 In vitro test market, 2012 - 2022 (USD Million)
Chapter 8 Allergy Therapeutics Drug Class Outlook
                   8.1 Global allergy therapeutics market share, by drug class, 2014 & 2022
                   8.2 Antihistamines
                      8.2.1 Antihistamines market, 2012 - 2022 (USD Million)
                   8.3 Corticosteroids
                      8.3.1 Corticosteroids market, 2012 - 2022 (USD Million)
                   8.4 Mast Cell Stabilizers
                      8.4.1 Mast Cell Stabilizers market, 2012 - 2022 (USD Million)
                   8.5 Leukotriene Inhibitors
                      8.5.1 Leukotriene Inhibitors market, 2012 - 2022 (USD Million)
                   8.6 Nasal anticholinergics
                      8.6.1 Nasal anticholinergics market, 2012 - 2022 (USD Million)
                   8.7 Decongestants
                      8.7.1 Decongestants market, 2012 - 2022 (USD Million)
                   8.8 Immunomodulators
                      8.8.1 Immunomodulators market, 2012 - 2022 (USD Million)
                   8.9 Autoinjectable Epinephrine
                      8.9.1 Autoinjectable epinephrine market, 2012 - 2022 (USD Million)
                   8.10 Immunotherapy
                      8.10.1 Immunotherapy market, 2012 - 2022 (USD Million)
Chapter 9 Allergy Diagnostics Regional Outlook
                   9.1 Allergy Diagnostics market share, by region, 2014 & 2022
                   9.2 North America
                      9.2.1 North America allergy diagnostics market, 2012 - 2022 (USD Million)
                      9.2.2 North America allergy therapeutics market, 2012 - 2022 (USD Million)
                      9.2.3 U.S.
                           9.2.3.1 U.S. Allergy Diagnostics market, 2012 - 2022 (USD Million)
                           9.2.3.2 U.S. allergy therapeutics market, 2012 - 2022 (USD Million)
                   9.3 Europe
                      9.3.1 Europe Allergy Diagnostics market, 2012 - 2022 (USD Million)
                      9.3.2 Europe allergy therapeutics market, 2012 - 2022 (USD Million)
                      9.3.3 Germany
                           9.3.3.1 Germany Allergy Diagnostics market, 2012 - 2022 (USD Million)
                           9.3.3.2 Germany allergy therapeutics market, 2012 - 2022 (USD Million)
                      9.3.4 UK
                           9.3.4.1 UK allergy diagnostics market, 2012 - 2022 (USD Million)
                           9.3.4.2 UK allergy therapeutics market, 2012 - 2022 (USD Million)
                   9.4 Asia Pacific
                      9.4.1 Asia Pacific allergy diagnostics market, 2012 - 2022 (USD Million)
                      9.4.2 Asia Pacific allergy therapeutics market, 2012 - 2022 (USD Million)
                      9.4.3 Japan
                           9.4.3.1 Japan allergy diagnostics market, 2012 - 2022 (USD Million)
                           9.4.3.2 Japan allergy therapeutics market, 2012 - 2022 (USD Million)
                      9.4.4 China
                           9.4.4.1 China allergy diagnostics market, 2012 - 2022 (USD Million)
                           9.4.4.2 China allergy therapeutics market, 2012 - 2022 (USD Million)
                   9.5 Latin America
                      9.5.1 Latin America allergy diagnostics market, 2012 - 2022 (USD Million)
                      9.5.2 Latin America allergy therapeutics market, 2012 - 2022 (USD Million)
                      9.5.3 Brazil
                           9.5.3.1 Brazil allergy diagnostics market, 2012 - 2022 (USD Million)
                           9.5.3.2 Brazil allergy therapeutics market, 2012 - 2022 (USD Million)
                   9.6 MEA
                      9.6.1 MEA allergy diagnostics market, 2012 - 2022 (USD Million)
                      9.6.2 MEA allergy therapeutics market, 2012 - 2022 (USD Million)
                      9.6.3 South Africa
                           9.6.3.1 South Africa allergy diagnostics market, 2012 - 2022 (USD Million)
                           9.6.3.2 South Africa allergy therapeutics market, 2012 - 2022 (USD Million)
Chapter 10 Competitive Landscape
                   10.1 bioMerieux
                      10.1.1 Company Overview
                      10.1.2 Financial Performance
                      10.1.3 Product Benchmarking
                      10.1.4 Strategic Initiatives
                   10.2 Danaher Corporation
                      10.2.1 Company Overview
                      10.2.2 Beckman Coulter
                      10.2.3 Financial Performance
                      10.2.4 Product Benchmarking
                      10.2.5 Strategic Initiatives
                   10.3 Thermo Fisher Scientific
                      10.3.1 Company Overview
                      10.3.2 Financial Performance
                      10.3.3 Product Benchmarking
                      10.3.4 Strategic Initiatives
                   10.4 Stallergenes Greer
                      10.4.1 Company Overview
                      10.4.2 Financial Performance
                      10.4.3 Product Benchmarking
                      10.4.4 Strategic Initiatives
                   10.5 Hitachi Chemical Diagnostics
                      10.5.1 Company Overview
                      10.5.2 Financial Performance
                      10.5.3 Product Benchmarking
                      10.5.4 Strategic Initiatives
                   10.6 Siemens Healthcare
                      10.6.1 Company Overview
                      10.6.2 Financial Performance
                      10.6.3 Service Benchmarking
                      10.6.4 Strategic Initiatives
                   10.7 Omega Diagnostics
                      10.7.1 Company Overview
                      10.7.2 Financial Performance
                      10.7.3 Product Benchmarking
                      10.7.4 Strategic Initiatives
                   10.8 Hycor Biomedical
                      10.8.1 Company Overview
                      10.8.2 Financial Performance
                      10.8.3 Product Benchmarking
                      10.8.4 Strategic Initiatives
                   10.9 Lincoln Diagnostics
                      10.9.1 Company Overview
                      10.9.2 Financial Performance
                      10.9.3 Product Benchmarking
                      10.9.4 Strategic Initiatives
                   10.10 HOB Biotech Group
                      10.10.1 Company Overview
                      10.10.2 Financial Performance
                      10.10.3 Product Benchmarking
                      10.10.4 Strategic Initiatives
                   10.11 Alcon Laboratories, Inc.
                      10.11.1 Company Overview
                      10.11.2 Financial Performance
                      10.11.3 Product Benchmarking
                      10.11.4 Strategic Initiatives

List of Tables

TABLE 1 Allergy Diagnostics- Industry Snapshot & Key Buying Criteria, 2012 - 2022
TABLE 2 Global allergy therapeutics and diagnostics market, 2012-2022(USD Million)
TABLE 3 Global allergy diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 4 Global allergy diagnostics market, by allergen type, 2012 - 2022 (USD Million)
TABLE 5 Global allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 6 Global allergy diagnostics market, by type of test, 2012 - 2022 (USD Million)
TABLE 7 Global allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)
TABLE 8 Global allergy diagnostics market, by region, 2012 - 2022 (USD Million)
TABLE 9 Allergy Diagnostics- Key market driver analysis
TABLE 10 Healthcare expenditure levels, 2013
TABLE 11 Allergy Daignsotics- Key market restraint analysis
TABLE 12 Allergy Therapeutics - Pipeline Overview
TABLE 13 North America allergy diagnostics market, by product, 2012- 2022 (USD Million)
TABLE 14 North America allergy diagnostics market, by type of allergens, 2012 - 2022 (USD Million)
TABLE 15 North America allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 16 North America allergy diagnostics market, by test outlook, 2012 - 2022 (USD Million)
TABLE 17 North America In Vivo/ Skin market, by types, 2012 - 2022 (USD Million)
TABLE 18 North America allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)
TABLE 19 U.S. allergy diagnostics market, by product, 2012- 2022 (USD Million)
TABLE 20 U.S. allergy diagnostics market, by type of allergens, 2012 - 2022 (USD Million)
TABLE 21 U.S. allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 22 U.S. allergy diagnostics market, by test outlook, 2012 - 2022 (USD Million)
TABLE 23 U.S. In Vivo/ Skin market, by types, 2012 - 2022 (USD Million)
TABLE 24 U.S. allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)
TABLE 25 Europe allergy diagnostics market, by product, 2012- 2022 (USD Million)
TABLE 26 Europe diagnostics market, by type of allergens, 2012 - 2022 (USD Million)
TABLE 27 Europe allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 28 Europe allergy diagnostics market, by test outlook, 2012 - 2022 (USD Million)
TABLE 29 Europe In Vivo/ Skin market, by types, 2012 - 2022 (USD Million)
TABLE 30 Europe allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)
TABLE 31 Germany allergy diagnostics market, by product, 2012- 2022 (USD Million)
TABLE 32 Germany allergy diagnostics market, by type of allergens, 2012 - 2022 (USD Million)
TABLE 33 Germany allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 34 Germany allergy diagnostics market, by test outlook, 2012 - 2022 (USD Million)
TABLE 35 Germany In Vivo/ Skin market, by types, 2012 - 2022 (USD Million)
TABLE 36 Germany allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)
TABLE 37 UK allergy diagnostics market, by product, 2012- 2022 (USD Million)
TABLE 38 UK allergy diagnostics market, by type of allergens, 2012 - 2022 (USD Million)
TABLE 39 UK allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 40 UK allergy diagnostics market, by test outlook, 2012 - 2022 (USD Million)
TABLE 41 UK In Vivo/ Skin market, by types, 2012 - 2022 (USD Million)
TABLE 42 UK allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)
TABLE 43 Asia Pacific allergy diagnostics market, by product, 2012- 2022 (USD Million)
TABLE 44 Asia Pacific allergy diagnostics market, by type of allergens, 2012 - 2022 (USD Million)
TABLE 45 Asia Pacific allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 46 Asia Pacific allergy diagnostics market, by test outlook, 2012 - 2022 (USD Million)
TABLE 47 Asia Pacific In Vivo/ Skin market, by types, 2012 - 2022 (USD Million)
TABLE 48 Asia Pacific allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)
TABLE 49 Japan allergy diagnostics market, by product, 2012- 2022 (USD Million)
TABLE 50 Japan allergy diagnostics market, by type of allergens, 2012 - 2022 (USD Million)
TABLE 51 Japan allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 52 Japan allergy diagnostics market, by test outlook, 2012 - 2022 (USD Million)
TABLE 53 Japan In Vivo/ Skin market, by types, 2012 - 2022 (USD Million)
TABLE 54 Japan allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)
TABLE 55 China allergy diagnostics market, by product, 2012- 2022 (USD Million)
TABLE 56 China allergy diagnostics market, by type of allergens, 2012 - 2022 (USD Million)
TABLE 57 China allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 58 China allergy diagnostics market, by test outlook, 2012 - 2022 (USD Million)
TABLE 59 China In Vivo/ Skin market, by types, 2012 - 2022 (USD Million)
TABLE 60 China allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)
TABLE 61 Latin America allergy diagnostics market, by product, 2012- 2022 (USD Million)
TABLE 62 Latin America allergy diagnostics market, by type of allergens, 2012 - 2022 (USD Million)
TABLE 63 Latin America allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 64 Latin America allergy diagnostics market, by test outlook, 2012 - 2022 (USD Million)
TABLE 65 Latin America In Vivo/ Skin market, by types, 2012 - 2022 (USD Million)
TABLE 66 Latin America allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)
TABLE 67 Brazil allergy diagnostics market, by product, 2012- 2022 (USD Million)
TABLE 68 Brazil allergy diagnostics market, by type of allergens, 2012 - 2022 (USD Million)
TABLE 69 Brazil allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 70 Brazil allergy diagnostics market, by test outlook, 2012 - 2022 (USD Million)
TABLE 71 Brazil In Vivo/ Skin market, by types, 2012 - 2022 (USD Million)
TABLE 72 Brazil allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)
TABLE 73 MEA allergy diagnostics market, by product, 2012- 2022 (USD Million)
TABLE 74 MEA allergy diagnostics market, by type of allergens, 2012 - 2022 (USD Million)
TABLE 75 MEA allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 76 MEA allergy diagnostics market, by test outlook, 2012 - 2022 (USD Million)
TABLE 77 MEA In Vivo/ Skin market, by types, 2012 - 2022 (USD Million)
TABLE 78 MEA allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)
TABLE 79 South Africa allergy diagnostics market, by product, 2012- 2022 (USD Million)
TABLE 80 South Africa allergy diagnostics market, by type of allergens, 2012 - 2022 (USD Million)
TABLE 81 South Africa allergy diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 82 South Africa allergy diagnostics market, by test outlook, 2012 - 2022 (USD Million)
TABLE 83 South Africa In Vivo/ Skin market, by types, 2012 - 2022 (USD Million)
TABLE 84 South Africa allergy therapeutics market, by drug class, 2012 - 2022 (USD Million)